Continued high-level co-ordination between the off-patent industry, regulators and the European Commission is key to ensure that the region continues to effectively address the coronavirus pandemic, as well as preparing itself for future similar crises, according to participants at a roundtable hosted by off-patent industry association Medicines for Europe.
Speaking today as part of a panel at a webinar on “lessons learned from COVID-19” Teva’s Christoph Stoller, president of...




